ArticleNPJ digital medicine2025
Fast multimodal imaging combined with machine learning identifying taurine as a potential marker for breast cancer margin assessment.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07681245 (Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Sensitive and accurate determination of margins between breast-conserving surgery (BCS) is challenging. This study provided a novel approach and biomarker for margin detection of BC through multi-modality imaging of femtosecond label-free imaging (FLI) microscopy and imaging mass spectrometry (IMS) plus machine learning (ML). The regions of interest (ROI) identified by FLI microscopy closely match tissue micro-regions diagnosed by pathologists. Additionally, a biomarker panel comprising taurine, threonate, and glutamate was established for classifying BC and tumor-adjacent noncancerous breast (TANB) tissues. Among these, taurine with higher abundance was confirmed as a potential biomarker to assess positive margins. Elevated level of taurine was associated with poor overall survival in BC patients. Functional analysis validated pro-tumorigenic effect of taurine in BC cell lines. Overall, the integration of FLI microscopy and IMS enables rapid visualization of cellular structures and metabolites in unlabeled tissues, with further analysis identifying taurine as a potential biomarker for margin evaluation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.